Officials are investigating the possibility that Johnson & Johnson's coronavirus vaccine might slightly raise the risk of a rare neurological complication known as Guillain-Barré syndrome.
Emergent Biosolutions To Resume Production Of Johnson & Johnson COVID-19 Vaccine
WJZ Baltimore
The FDA announced that they will allow Emergent Biosolutions to resume production of the Johnson and Johnson covid-19 vaccine on..
